[go: up one dir, main page]

GB0203018D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0203018D0
GB0203018D0 GB0203018A GB0203018A GB0203018D0 GB 0203018 D0 GB0203018 D0 GB 0203018D0 GB 0203018 A GB0203018 A GB 0203018A GB 0203018 A GB0203018 A GB 0203018A GB 0203018 D0 GB0203018 D0 GB 0203018D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0203018A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0203018A priority Critical patent/GB0203018D0/en
Publication of GB0203018D0 publication Critical patent/GB0203018D0/en
Ceased legal-status Critical Current

Links

GB0203018A 2002-02-08 2002-02-08 Antibodies Ceased GB0203018D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0203018A GB0203018D0 (en) 2002-02-08 2002-02-08 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203018A GB0203018D0 (en) 2002-02-08 2002-02-08 Antibodies

Publications (1)

Publication Number Publication Date
GB0203018D0 true GB0203018D0 (en) 2002-03-27

Family

ID=9930715

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203018A Ceased GB0203018D0 (en) 2002-02-08 2002-02-08 Antibodies

Country Status (1)

Country Link
GB (1) GB0203018D0 (en)

Similar Documents

Publication Publication Date Title
EP1494693A4 (en) Cripto-specific antibodies
PL375405A1 (en) Antibodies
EP1616881A4 (en) Anti-mpl antibodies
PT1599504E (en) Modified antibody
GB0426043D0 (en) Antibodies
AU2003217912A8 (en) Antibody optimization
EP1432444A4 (en) Anti-a-beta antibodies
GB0228210D0 (en) Single chain antibodies
GB0208331D0 (en) Proteins
GB0209884D0 (en) Proteins
EP1677112A4 (en) Immunoassay
GB0305448D0 (en) Immunoassay
GB0306618D0 (en) Antibody
EP1487874A4 (en) Falp proteins
GB0226878D0 (en) Antibodies
GB0212067D0 (en) Proteins
PL376318A1 (en) Protein modification
AU2003270055A8 (en) Neurotransmission-associated proteins
AU2003300785A8 (en) Carbohydrate-associated proteins
GB0218232D0 (en) Antibodies
GB0218230D0 (en) Antibodies
GB0203018D0 (en) Antibodies
GB0210508D0 (en) Antibodies
GB0218234D0 (en) Antibodies
GB0218229D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)